Companies / Bangladesh
WTO Boost For Bangladeshi Drug Industry
January 2006 | Company Finance AlertBangladesh’s pharmaceutical industry is set to receive a boost after a World Trade Organisation (WTO) ruling allowing so-called least developed countries (LDCs) to manufacture and export patented drugs until 2016. The decision came after the WTO recognised the gravity of public health problems afflicting such countries, especially HIV/AIDS, tuberculosis, malaria and other major disease
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
